Ariel Graff
Ariel Graff
Associate Professor
Verified email at - Homepage
Cited by
Cited by
Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology
OD Howes, R McCutcheon, O Agid, A De Bartolomeis, NJM Van Beveren, ...
American Journal of Psychiatry 174 (3), 216-229, 2017
Differential Effects of Aripiprazole on D 2 , 5-HT 2 , and 5-HT 1A Receptor Occupancy in Patients With Schizophrenia: A Triple …
D Mamo, A Graff, R Mizrahi, CM Shammi, F Romeyer, S Kapur
American Journal of Psychiatry 164 (9), 1411-1417, 2007
Cerebral blood flow associated with creative performance: a comparative study
RA Chávez-Eakle, A Graff-Guerrero, JC García-Reyna, V Vaugier, ...
Neuroimage 38 (3), 519-528, 2007
Higher levels of glutamate in the associative-striatum of subjects with prodromal symptoms of schizophrenia and patients with first-episode psychosis
C De La Fuente-sandoval, P León-Ortiz, R Favila, S Stephano, D Mamo, ...
Neuropsychopharmacology 36 (9), 1781-1791, 2011
Incentive motivation deficits in schizophrenia reflect effort computation impairments during cost-benefit decision-making
G Fervaha, A Graff-Guerrero, KK Zakzanis, G Foussias, O Agid, ...
Journal of psychiatric research 47 (11), 1590-1596, 2013
Defining treatment-resistant schizophrenia and response to antipsychotics: a review and recommendation
T Suzuki, G Remington, BH Mulsant, H Uchida, TK Rajji, A Graff-Guerrero, ...
Psychiatry research 197 (1-2), 1-6, 2012
Adverse subjective experience with antipsychotics and its relationship to striatal and extrastriatal D 2 receptors: a PET study in schizophrenia
R Mizrahi, P Rusjan, O Agid, A Graff, DC Mamo, RB Zipursky, S Kapur
American Journal of Psychiatry 164 (4), 630-637, 2007
Glutamate levels in the associative striatum before and after 4 weeks of antipsychotic treatment in first-episode psychosis: a longitudinal proton magnetic resonance …
C de la Fuente-Sandoval, P León-Ortiz, M Azcárraga, S Stephano, ...
JAMA psychiatry 70 (10), 1057-1066, 2013
Temporal difference modeling of the blood-oxygen level dependent response during aversive conditioning in humans: effects of dopaminergic modulation
M Menon, J Jensen, I Vitcu, A Graff-Guerrero, A Crawley, MA Smith, ...
Biological psychiatry 62 (7), 765-772, 2007
Repetitive transcranial magnetic stimulation of dorsolateral prefrontal cortex increases tolerance to human experimental pain
A Graff-Guerrero, J González-Olvera, A Fresán, D Gómez-Martín, ...
Cognitive brain research 25 (1), 153-160, 2005
The potential role of dopamine D3 receptor neurotransmission in cognition
S Nakajima, P Gerretsen, H Takeuchi, F Caravaggio, T Chow, B Le Foll, ...
European Neuropsychopharmacology 23 (8), 799-813, 2013
Dopamine D2 receptor occupancy and clinical effects: a systematic review and pooled analysis
H Uchida, H Takeuchi, A Graff-Guerrero, T Suzuki, K Watanabe, ...
Journal of clinical psychopharmacology 31 (4), 497-502, 2011
Treatment resistant schizophrenia and response to antipsychotics: a review
T Suzuki, G Remington, BH Mulsant, TK Rajji, H Uchida, A Graff-Guerrero, ...
Schizophrenia research 133 (1-3), 54-62, 2011
The dopamine D 2 receptors in high-affinity state and D 3 receptors in schizophrenia: a clinical [11 C]-(+)-PHNO PET study
A Graff-Guerrero, R Mizrahi, O Agid, H Marcon, P Barsoum, P Rusjan, ...
Neuropsychopharmacology 34 (4), 1078-1086, 2009
Glutamate-mediated excitotoxicity in schizophrenia: a review
E Plitman, S Nakajima, C de la Fuente-Sandoval, P Gerretsen, ...
European Neuropsychopharmacology 24 (10), 1591-1605, 2014
First human evidence of d-amphetamine induced displacement of a D 2/3 agonist radioligand: A [11 C]-(+)-PHNO positron emission tomography study
M Willeit, N Ginovart, A Graff, P Rusjan, I Vitcu, S Houle, P Seeman, ...
Neuropsychopharmacology 33 (2), 279-289, 2008
Motivational deficits and cognitive test performance in schizophrenia
G Fervaha, KK Zakzanis, G Foussias, A Graff-Guerrero, O Agid, ...
JAMA psychiatry 71 (9), 1058-1065, 2014
Brain region binding of the D2/3 agonist [11C]‐(+)‐PHNO and the D2/3 antagonist [11C]raclopride in healthy humans
A Graff‐Guerrero, M Willeit, N Ginovart, D Mamo, R Mizrahi, P Rusjan, ...
Human brain mapping 29 (4), 400-410, 2008
Kynurenic acid in schizophrenia: a systematic review and meta-analysis
E Plitman, Y Iwata, F Caravaggio, S Nakajima, JK Chung, P Gerretsen, ...
Schizophrenia bulletin 43 (4), 764-777, 2017
Effects of risperidone and olanzapine dose reduction on cognitive function in stable patients with schizophrenia: an open-label, randomized, controlled, pilot study
H Takeuchi, T Suzuki, G Remington, RR Bies, T Abe, A Graff-Guerrero, ...
Schizophrenia bulletin 39 (5), 993-998, 2013
The system can't perform the operation now. Try again later.
Articles 1–20